Open access peer-reviewed chapter

Recent Advancement in Therapeutic Activity of Carotenoids

Written By

Anju Singh and Kamya Omer

Submitted: 26 June 2023 Reviewed: 17 July 2023 Published: 20 March 2024

DOI: 10.5772/intechopen.112580

From the Edited Volume

Dietary Carotenoids - Sources, Properties, and Role in Human Health

Edited by Akkinapally Venketeshwer Rao and Leticia Rao

Chapter metrics overview

36 Chapter Downloads

View Full Metrics

Abstract

Carotenoids are a class of organic pigments that are widely distributed in nature and are responsible for the bright colours of many fruits and vegetables. Carotenoids are found in many plant-based foods such as carrots, sweet potatoes, spinach, kale, and tomatoes. Some of the most well-known carotenoids include beta-carotene, lutein, zeaxanthin, and lycopene. Lutein and zeaxanthin are concentrated in the eyes and have been shown to protect against age-related macular degeneration, a leading cause of blindness in the elderly. Lycopene is found in high concentrations in tomatoes and has been associated with a reduced risk of prostate cancer. Recent research has focused on the potential therapeutic applications of carotenoids for the treatment of various diseases. For example, astaxanthin, a carotenoid found in salmon and other seafood, has been shown to have anti-inflammatory and antioxidant properties and may be useful in the treatment of conditions such as arthritis and cardiovascular disease. Similarly, lycopene has been investigated for its potential to prevent or treat certain types of cancer, including prostate, lung, and breast cancer. In addition to their potential health benefits, carotenoids are also being studied for their role in the prevention of cognitive decline and ageing-related diseases. Ongoing research is exploring their potential therapeutic applications for the treatment of various conditions, including cancer, cardiovascular disease, and cognitive decline. On completion of the chapter you shall be able to explain: (1) the sources and classification of carotenoids, (2) the bioactive compounds used to in various treatments and (3) novel discoveries related to carotenoids.

Keywords

  • carotenoids
  • therapeutic activity
  • bioactive compounds
  • carotene
  • xanthophylls
  • disease prevention and treatment

1. Introduction

The vibrant colours found in fruits and vegetables are due to carotenoids, a type of pigment. Carotenoids are dietary tetraterpenoid (C40 containing eight isoprenoid residues) chemicals that play an important function in cell defence [1, 2].

These naturally occurring, lipid-soluble, highly unsaturated red, yellow, or orange pigments are found in plants, fungus, bacteria, and algae, and the quantity of carotenoids determines how intense the colour is. As naturally occurring elements of fruits and vegetables, these have been widely distributed. Carotenoids are responsible for the coloration of many flowers, birds, and marine animals [3]. Carotenoids’ therapeutic activities and actions are determined by their molecular structure, that defines their physical and chemical qualities.

It’s interesting to know that there are approximately 600 known carotenoids, and some experts think the actual number may be closer to 750. However, only 100 of these carotenoids are commonly found in the food we eat. The top five carotenoids, such as α-carotene, β-carotene, lycopene, β-cryptoxanthin, lutein, and zeaxanthin, make up a significant 95% of our diet. These carotenoids have been extensively researched over the years, as they play crucial roles in photobiology, photochemistry, and photomedicine [4].

Carotenoids are frequently referred to as provitamin A because this vitamin is a by-product of carotenoid metabolism. They are gaining popularity due to their supposed antioxidant effects. Decades of research on carotenoids have improved our understanding of their role as important players in the prevention of ageing-related diseases such as cancer, cardiovascular disease, cataracts, and age-related macular degeneration [5]. Carotenoids’ numerous health advantages have motivated their incorporation in foods and beverages as nutraceuticals and nutritional supplements.

Carotenoids research is progressing in three major areas:

  • Carotenoids production from natural sources and downstream processing optimisation;

  • the encapsulation for improved physical as well as chemical properties; and

  • preclinical, clinical, and epidemiological evaluations of carotenoids health benefits. Carotenoids are crucial bioactive molecules that have a significant impact on human health.

They can be present in a broad range of foods made from plants and have been linked to a lower risk for long-term diseases. Global demand for carotenoids is expected to rise from a value of US$1.5 billion in 2014 to a total of US$1.8 billion in 2019. Carotenoids from natural sources are used to make some of the commercially available carotenoids. Synthetic carotenoids have some advantages over natural carotenoids. First, synthesised carotenoids are particularly constructed to minimise oxidation or isomerization, making them more stable. Synthetic carotenoids are created in colloidal suspension, emulsification, and dispersion colloids to make carotenoid application in food easier. They are commonly sold on the market as soluble in water and stable emulsions.

Despite these benefits, chemically produced carotenoids are known to have significant levels of toxicity, carcinogenicity, and teratogenicity. As a result, customers who care about their health have a lot of reservations about them. As a result, carotenoids derived from natural resources are highly sought after by today’s customers.

Advertisement

2. Chemistry of carotenoids

Carotenoids are a class of pigments found mostly in plants that are responsible for the vibrant yellow, orange, and red colours found in vegetables and fruits [6]. All have antioxidant action, and some are vitamin A precursors. Furthermore, carotenoids play a function in interaction between cells, immune system activation, and illness prevention, promoting human health [7].

Carotenoids are made up of eight repeating units of isoprene with cyclic or linear structures at both ends, resulting in numerous cis and trans isomers, with the latter type being more prevalent in nature [8].

Advertisement

3. Classification of carotenoids

Carotenoids are categorised based on their chemical structure or their usefulness.

  1. Chemical structure: Carotenoids that are found as pure hydrocarbons are known as carotenes, including α-carotene, β-carotene, and lycopene. On the other hand, xanthophylls are carotenoids that have oxygen as a functional group in their structure, such as β-cryptoxanthin, lutein, and zeaxanthin. It’s worth noting that the presence of polar groups, like epoxy, hydroxyl, and keto, in the structure can have an impact on the polarity and biological activity of the compounds [4].

  2. Functionality: carotenoids can also be classified as primary or secondary carotenoids.

Primary carotenoids are photosynthetic pigments that play an important role in photosynthesis. Carotenes with orange to red wavelengths are responsible for transporting light energy from chlorophyll-absorbed sunlight. They are also known to operate as plant antioxidants by collecting energy from singlet oxygen generated during photosynthesis [9]. Xanthophyll molecules, on the other hand, are plentiful in plant leaves but do not play a direct role in photosynthesis. Xanthophylls absorb a wavelength of sunlight that chlorophyll does not. Plants use them as secondary carotenoids or as supplementary pigments.

3.1 Xanthophylls

Xanthophylls are soluble in both polar (e.g., alcohols) and organic (e.g., ether and hexane) solvents.

Xanthophylls are made up of hydrogen, carbon, and one or more functional groups including oxygen. They are oxygenated carotenoid derivatives that generate alcohols, aldehydes, ketones, and acids. Fucoxanthin, lutein, and violaxanthin are examples of xanthophylls.

Xanthophylls are naturally present in the tissues of green plants, but they only appear as fatty acid esters in fruits and flowers.

They are, however, slightly soluble in oils at ambient temperature as well as non-polar organic solvents such as chloroform and acetone.

3.2 Carotenes

Carotenes are pure hydrocarbons. Plants and numerous microorganisms synthesise carotenoids in nature [10]. Animals can metabolise them in a specific way, but they cannot synthesise them. Carotenoids degrade slowly in storage, with losses varying depending on the matrix and storage circumstances [11].

Plant tissues, or plastids, such as chromoplasts (coloured plastids), amyloplasts (starch storage plastids), and elaioplasts (lipid storage plastids), are where carotenoids are stored. Carotenoids are found in the chromoplasts of fruits, flowers, and roots, whereas they are found in the amyloplasts and elaioplasts of grains and oilseeds, respectively.

Plants’ carotenoids are typically lipid-based and insoluble in water; they are found in the chloroplast cells. Due to their water insolubility, they do not leach away when the veggies are prepped and cooked. They also do not significantly alter colour with heat or pH, especially if the chloroplast cells are still largely intact.

Carotenoids are terpenoids that are synthesised from the fundamental C5-terpenoid precursor, isopentyl diphosphate. Geranyl-geranyl diphosphate is formed from this chemical [11]. Its dimerisation produces phytoene, which is then dehydrogenated stepwise via phytofluene, zeta-carotene, and neyrosporene to produce lycopene. The additional naturally occurring carotenoids are produced through further oxidation, dehydrogenation, and cyclization processes.

Technology has advanced to the point that it is now possible to synthesise carotenoids with well-controlled, reproducible hues, without quality variations, and in a volume that can be scheduled to suit the needs of the food industry [12].

Advertisement

4. Natural occurrence of carotenoids

Only 40 of the more than 700 known carotenoids are present in the diet of humans, with α-carotene, β-carotene, lycopene, β-cryptoxanthin, lutein, and zeaxanthin being the most prevalent ones (Table 1) [44].

CarotenoidsBiological sourceCommon namePharmacological activityReferences
α-CaroteneDaucus carotaCarrotAntioxidant, anti-carcinogenic, immune function enhancing, and lower risk of cardiovascular disease.Mangels et al. [16]; Holden et al. [17]; Tanumihardjo [18]
Citrus spp.Orange
Carica papayaPapaya
Musa acuminateBanana
Prunus armeniacaApricot
β-CaroteneLactuca sativaLettuceLower occurrences of certain cancers (lung cancer), enhance the immune function, antioxidant and anti-inflammatory.Harrison [19]; Wawrzyinak et al. [20]; Stahl and Sies [21]; Bendich [22]; Liebler and Mcclure [23]; Fiedor and Burda [24]; Böhm et al. [25]
Citrus paradiseGrapefruit
Prunus armeniacaApricot
Brassica oleraceaBroccoli
Daucus carotaCarrot
β-CryptoxanthinCapsicum annuumRed pepperAntioxidant, anti-obesity, anti-inflammatory, anti-osteoporosis and anticancerBurri [26]; Burri et al. [27]; Coronel et al. [28]; Jiao et al. [29]
Prunus armeniacaApricot
Mangifera indicaMango
Curcubita spp.Pumpkin
Curcubita moschataPumpkin or Squash
LuteinSpinacia oleraceaSpinachAntioxidant, anti-inflammatory, autophagy, neuroprotective, photo protection, hepatoprotective, immunomodulation, anti-carcinogenicKrinsky et al. [30]; Xu et al. [31]; Woodside et al. [32]; Eisenhauer et al. [33]; Cho et al. [34]
Citrus spp.Orange
Zea maysCorn
Capsicum annuumRed pepper
Brassica oleraceaBroccoli
LycopeneSolanum lycopersicumTomatoEnhance immunity, antioxidant, anti-proliferative, anticancer, anti-inflammatory, cognition enhancer, neuroprotective, hepatoprotective, bone protective, anti-obesity, anti-diabetic and against dermatologic diseaseDi Masico et al. [35]; Luo and Wu [36]; Agarwal and Rao [37]; Liu et al. [38]; Neyestani et al. [39]; Story et al. [40]; Aydin et al. [41]; Wang et al. [42]; Wang et al. [43]; Böhm et al. [25]
Carica papayaPapaya
Citrullus lanatusWatermelon
Prunus armeniacaApricot
Daucus carotaCarrot
ZeaxanthinZea maysCornAntioxidant, anti-inflammatory, neuroprotective, hepatoprotective, immunomodulation, anti-carcinogenic, and also to improve skin pliabilityKrinsky et al. [30]; Xu et al. [31]; Woodside et al. [32]; Eisenhauer et al. [33]; Cho et al. [34]; Böhm et al. [25]
Capsicum annuumRed pepper
Cucurbita moschataPumpkin
Diospyros kakiPersimmon
Malphigia punicifoliaAcerola

Table 1.

Carotenoids with their sources and bioactivity/pharmacological activity [13, 14, 15].

In paprika and pepper, the xanthophylls violaxanthin (yellow), capsanthin, and capsorubin (orange to red) are usually present. Neoxanthin, which has a yellow tint, is a naturally occurring component found in vegetable leaves. Saffron’s yellow hue can be attributed to crocin [45].

Some carotenoids can only be found in algae or seafood. Due to its natural occurrence in krill and the microalga hematococcus pulvialis, which are eaten by small crustaceans like prawn and crawfish, fish like salmon and birds like flamingos, astaxanthin gives prawn, salmon and flamingo feathers their pink-red hue.

Based on the levels of carotenoid in the foods, Britton and Khachik [46] developed a ranking of vegetables and fruits. They divided foods into the following categories:

  • Low (0–1 g/g),

  • Moderate (1–5 g/g),

  • High (5–20 g/g), and

  • Very High (>20 g/g) levels.

Many factors influence the composition and number of carotenoids in food, including:

  • Those inherent to the plant (variety, genotype, and ripening stage),

  • Plant external factors (harvest season, growth circumstances, post-harvest treatment, handling, storage conditions, plant diseases, and climatic variables)

Advertisement

5. Dietary carotenoids in foods

The main dietary carotenoids include the hydrocarbons beta-carotene, alpha-carotene, and lycopene, as well as the xanthophylls, or oxygen-containing carotenoids, cryptoxanthin, lutein, and zeaxanthin [47].

5.1 Beta-carotene

The most extensively researched carotenoid is beta-carotene, which is also a prominent carotenoid in our diet as well as in our blood and tissues. It is a bright red-orange pigment found in many plants and fruits. Green leafy vegetables, as well as orange and yellow fruits and vegetables [48], such as carrots, sweet potatoes, mangoes, pumpkin, kale, spinach, apricots, pepper, cantaloupe, lettuce, and tomato paste, are high in beta-carotene. Because carotenes are fat soluble, eating them with fat improves absorption.

5.2 Lycopene

Lycopene is a brilliant red carotene pigment and phytochemical that plants and microorganisms produce; absorbs light during photosynthesis and protect them from photosensitization. Despite being a carotene chemically, lycopene has no vitamin A action [47].

Heating tomatoes in oil was observed to be related with an increase in lycopene absorption when compared to unprocessed tomato juice absorption, similar to the effect on beta-carotene bioavailability [49]. Furthermore, lycopene bioavailability was higher with a single dose of tomato paste than with an identical lycopene dose of fresh tomatoes.

5.3 Lutein and zeaxanthin

Dark green leafy foods like spinach and kale contain lutein, a significant carotenoid [50]. Lutein is chemically distinct from other carotenoids. One of the most frequent carotenoid alcohols discovered in nature is zeaxanthin. Lutein and zeaxanthin are similar in terms of food sources, human metabolism, and tissue storage. Although the levels are modest in eggs, recent research indicates that both zeaxanthin and lutein from this kind of food are highly accessible.

Advertisement

6. Therapeutic activity of carotenoids

SeeFigure 1 [53, 54].

Figure 1.

Carotenoids to prevent disease [24, 51, 52].

6.1 Anti-ageing activity

One of the main signs of ageing is considered to be the onset and development of atherosclerosis. One of the causes of atherosclerosis is the inflammation-induced generation of reactive oxygen species (ROS) by atherosclerotic plaque.

Age-related blood vessel damage and endothelial dysfunction are caused by the degree of ROS present, which promotes the development of atherosclerosis. Additionally, a decrease in nitric oxide (NO) in the vascular tissue contributes to atherosclerosis and the ageing process brought on by ROS. However, the bioavailability or concentration of NO is often high in normal vascular tissue. Through a number of processes, including the preservation of normal blood flow in organs via flow/shear stress-mediated vasodilation, NO produced in the endothelium inhibits atherosclerotic vascular ageing. One of the primary ways for preventing anti-vascular ageing is maintained vasodilation, which mediates blood flow in organs.

Carotenoids such as lutein, lycopene, and others prevent vascular ageing by anti-oxidant action, which increases the bioavailability of NO in the vascular system. Tomato extracts containing -carotene and lycopene consistently lower blood pressure while increasing NO levels in the plasma [55].

Many other studies have demonstrated lycopene’s actions as an inhibitor of inflammation and ROS, as well as in the amelioration of inflammatory-mediated atherosclerotic processes. Specifically, lutein and lycopene, as well as other carotenoids, impede this process by lowering the level of ROS in biological systems. The anti-oxidant activity of lutein was demonstrated in vascular smooth muscle cells.

6.2 Osteo-protective activity

Carotenoids like β-cryptoxanthin have the ability to regulate the health of bone and inhibit osteoporosis. β-Cryptoxanthin intake increases calcium content and alkaline phosphatase activity in cortical bone and metaphyseal tissues in vitro, leading to a stimulatory effect on bone resorption, which eventually minimises the risk of osteoporosis. The intake of reinforce juice which has higher β-cryptoxanthin than a usual juice, displayed a preventive action on loss of bone. Long term intake of juice containing β-cryptoxanthin results to activation of bone formation and preventive action on reabsorption of bone in humans, which is favourable among menopausal women.

6.3 Antioxidant activity

One of the most effective singlet oxygen scavengers in nature has been shown to be carotenoids, which have a quick quenching rate (1010 M1 s1). They can effectively neutralise ROS and other free radicals to provide oxidation protection for both photosynthetic and non-photosynthetic species. Many epidemiological and clinical research have been conducted to determine whether carotenoids have the ability to protect various ROS-mediated illnesses such as cancer, inflammation, retinal degeneration, and neurodegeneration [56].

Carotenoids have antioxidant properties, but they can also activate endogenous antioxidant enzymatic activity and reduce DNA damage to shield cells from the oxidative stress brought on by specific stimuli. Crocetin, a pharmacologically active metabolite of Crocus sativus L., shows cardioprotective benefits by enhancing superoxide dismutase (SOD) and glutathione peroxidase activity in ventricular hypertrophy. It has also been demonstrated that crocin, another Crocus sativus L. component, increases SOD activity to stop PC-12 cells from dying when they are denied glucose or serum.

Recent research has shown that marine carotenoids like astaxanthin and fucoxanthin exhibit antioxidant characteristics as well by energising the antioxidant network, which includes SOD and catalase [30]. In addition, beta-cryptoxanthin shields human cells from H2O2-induced harm by promoting DNA oxidation-related damage repair in addition to its antioxidant activities. At low doses, lycopene and -carotene also protect against DNA damage. However, at greater concentrations, the opposite effects have been observed in cells undergoing oxidative damage [14].

6.4 Effect of carotenoids on neurodegenerative disease

Neurodegenerative diseases are neuronal disorders characterised by increasing neuronal loss and protein aggregation [34]. The most common neurodegenerative disorders are Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), and amyotrophic lateral sclerosis (ALS). Although the causes of these neurodegenerative diseases differ, they share certain traits that may be intimately associated to disease start and progression through inducing neuronal cell death.

One common trait is oxidative stress caused by increased ROS production throughout disease progression. ROS are reactive compounds containing oxygen that can target and damage live cell macromolecules such as lipids, DNA, and proteins. Various cellular processes, such as mitochondrial insults and the production of redox metals that interact with oxygen, raise the amount of ROS in the neuronal cells of patients with neurodegenerative disorders, which leads to neuronal cell death [57].

In a case of Alzheimer’s disease, the most studied neurodegenerative disease, multiple studies have found reduced quantities of carotenoids including beta-carotene, lutein, and vitamin A in the blood plasma of Alzheimer’s patients. A recent case-control study found that the concentration of six key carotenoids in serum (alpha-carotene, beta-carotene, beta-cryptoxanthin, lutein, lycopene, and zeaxanthin) was considerably lower in individuals with Alzheimer’s disease [58].

Carotenoid consumption reduced the risk of Alzheimer’s disease and the rate of cognitive deterioration. Antioxidant supplementation, like astaxanthin and a vitamin complex containing alpha-tocopherol, ascorbic acid, and beta-carotene, lowered Aβ levels in red blood cells and ROS production in AD patients’ cells, respectively [59].

Carotenoids’ diverse modes of action are expected to occur concurrently in neurodegenerative disease states. Lycopene, for example, reduced A-induced mitochondrial dysfunction, inflammatory cytokine mediators, and caspase-3 activity all at the same time. A-induced damage was reduced in a cultured cell model by astaxanthin administration by many pathways, including downregulation of apoptotic factors, suppression of inflammatory cytokine mediating activity, and concomitant reduction of ROS.

6.5 Anticancer activity

A carotenoid can help prevent cancer through a variety of processes. A carotenoid, as a provitamin A, would influence cellular differentiation and proliferation. Furthermore, the antioxidant action may protect cellular DNA and other components from free radical damage Immunomodulatory effects may improve immune surveillance during carcinogenesis and improved cell-cell communication may limit the clonal proliferation of started cells.

Carotenoids are known to stop the cell cycle in the majority of cases, which is related with decreased expression of cyclin D1, cyclin D2, CDK4 and CDK6. As a result, it up regulates GADD45, which blocks cell entrance into S phase [60].

Furthermore, chemicals derived from saffron such as crocin and crocetin demonstrated anti-metastasis properties such as anti-migration, anti-invasive, and anti-non-adhesive effects when used together on the 4T1 cell line in breast cancer [55, 61]. Carotenoids such as beta-cryptoxanthin and lycopene have been discovered to block the NF-B signalling pathway, which is effective for lung and prostate cancer. Beta-carotene has been proven to have anti-angiogenic action, which means it helps to prevent the formation of new blood vessels, which is common in malignant tumours.

6.6 Cardiovascular diseases

Carotenoids have been shown to reduce oxidative stress, inflammation, dyslipidaemia, and thrombosis, which are all factors in the development of cardiovascular disease.

Carotenoids appear to restore the endothelial bioavailability of nitric oxide (NO) by purging superoxide anion (O2), which is a direct cause of reactive oxygen species (ROS) formation [62]. By oxidising LDL and lowering HDL, some carotenoids, such as astaxanthin, lutein, and beta-cryptoxanthin, are proven to be more effective at avoiding cardiovascular disease. Myocardial damage and many other conditions can be treated with this [63].

6.7 Ophthalmic infections

Rhodopsin, a component of vitamin A, is essential for the efficient conversion of light energy from pictures into electrochemical impulses, which is a crucial function of the human eye [64]. Night blindness is a result of a vitamin A deficiency; it can be avoided by taking enough carotenoids, which will enhance vision. Only 10% of the carotenoids are categorised as provitamin A and later in vitamin A.

The oxygenated carotenoids lutein and zeaxanthin, which are essential for clear, detailed vision as well as for filtering the blue light from screens and removing free radicals from the retina, are found in the macular portion of the retina. They can also assist in preventing eye cataracts and macular degeneration associated with ageing.

6.8 Anti-hyperglycaemia

Uses of carotenoids by humans decreases the risk of type2 diabetes mellitus. Astaxanthin, a well-studied carotenoid, has better antioxidant characteristics than other carotenoids such as lutein, zeaxanthin, and beta-carotene, and it has been claimed to be useful in the prevention and control of diabetes [65]. The antioxidant properties of astaxanthin can help to maintain the morphology and function of beta cells.

The main cause of hyperglycaemia is lifestyle and eating choices. Hypertension causes oxidative stress, which complicates the body by linking it to obesity, diabetes, dyslipidaemia, and hyperhomocysteinemia. Here, fatty acid radicals and (ROS) play a crucial part in raising the body’s levels of GR, GPx, and other hormones that cause illnesses [66, 67]. Carotenoids restore regulatory signals to normal by scavenging fatty acid radicles and ROS [68].

6.9 Skin protection

The skin accumulates a lot of the carotenoids that are taken as part of a typical diet and uses them to defend itself from sunburn, ageing, and damage caused by UV rays [48]. Carotenoids, with their antioxidant and anti-inflammatory characteristics, as well as their capacity to regulate cell growth and division, can help protect the skin from photodamage and prevent skin disorders.

Several investigations showed that beta-carotene had a preventive effect against sunburn, or erythema, in clinical settings. The colourless carotenoids phytoene and phytofluene may also effectively shield the skin [69]. However, dietary carotenoids like lycopene or beta-carotene provide much lower levels of photoprotection than topical sunscreens do.

Advertisement

7. Conclusion

Carotenoids have emerged as fascinating natural compounds with significant potential for promoting public health and serving as therapeutic interventions. Their antioxidant, anti-inflammatory, immune-modulating, and photoprotective properties contribute to their diverse range of health benefits. Carotenoids have shown promise in preventing chronic diseases, supporting eye and skin health, and potentially serving as novel therapeutic agents.

However, further research is necessary to fully understand the mechanisms underlying the therapeutic activity of carotenoids, optimise their bioavailability, and establish evidence-based guidelines for their use. Rigorous clinical trials, nutrigenomic studies, and investigations into novel delivery systems are required to unlock the full potential of carotenoids for public health and therapeutic interventions [70].

Incorporating a varied and balanced diet rich in carotenoid-containing foods, along with considering the potential benefits of carotenoid supplementation under appropriate circumstances, may contribute to overall health and well-being. As scientific knowledge continues to expand, carotenoids hold promise as valuable components of preventive medicine and therapeutic strategies, offering opportunities for improving human health and reducing the burden of chronic diseases.

References

  1. 1. Meléndez-Martínez AJ et al. A comprehensive review on carotenoids in foods and feeds: Status quo, applications, patents, and research needs. Critical Reviews in Food Science and Nutrition. 2022;62(8):1999-2049
  2. 2. Saini RK, Nile SH, Park SW. Carotenoids from fruits and vegetables: Chemistry, analysis, occurrence, bioavailability and biological activities. Food Research International. 2015;76:735-750
  3. 3. Oehlenschläger J, Ostermeyer U. 13. Feed additives for influencing the color of fish and crustaceans. 2016. DOI: 10.1016/B978-0-08-100371-8.00013-0
  4. 4. Kiokias S, Proestos C, Varzakas T. A review of the structure, biosynthesis, absorption of carotenoids-analysis and properties of their common natural extracts. Current Research in Nutrition and Food Science Journal. 2016;4:25-37
  5. 5. Pradhan SP, Padhi S, Dash M, Heena BM, Behera A. Chapter 7 – Carotenoids. Nutraceuticals and Health Care. Academic Press; 2022. pp. 135-157. ISBN 9780323897792
  6. 6. González-Peña MA, Ortega-Regules AE, Anaya de Parrodi C, Lozada-Ramírez JD. Chemistry occurrence, properties, applications, and encapsulation of carotenoids—A review. Plants (Basel, Switzerland). 2023;12(2):313
  7. 7. Ngamwonglumlert L, Devahastin S. Carotenoids. Encyclopedia of Food Chemistry. Academic Press; 2019. pp. 40-52
  8. 8. Amorim-Carrilho KT, Cepeda A, Fente C, Regal P. Review of methods for analysis of carotenoids. TrAC Trends in Analytical Chemistry. 2014;56:49-73
  9. 9. Strati IF, Oreopoulou V. Recovery of carotenoids from tomato processing by-products – A review. Food Research International. 2014;65:311-321
  10. 10. Alcaino J, Baeza M, Cifuentes V. Carotenoid distribution in nature. Sub-cellular Biochemistry. 2016;79:3-33
  11. 11. Nagarajan J, Ramanan RN, Raghunandan ME, Galanakis CM, Krishnamurthy NP. Carotenoids. Nutraceutical and Functional Food Components. 2016. pp. 259-296
  12. 12. Solymosi K, Latruffe N, Morant-Manceau A, Schoefs B. Food colour additives of natural origin. In: Scotter MJ, editor. Colour Additives for Foods and Beverages. Oxford: Woodhead Publishing; 2015. pp. 3-34
  13. 13. Olatunde A, Tijjani H, Ishola AA, Egbuna C, Hassan S, Akram M. Carotenoids as functional bioactive compounds. In: Egbuna C, Dable Tupas G, editors. Functional Foods and Nutraceuticals. Cham: Springer; 25 August 2020. ISBN 978-3-030-42319-3
  14. 14. Khalil A, Tazeddinova D, Aljoumaa K, Kazhmukhanbetkyzy ZA, Orazov A, Toshev AD. Carotenoids: Therapeutic strategy in the Battle against viral emerging diseases, COVID-19: An overview. Preventive Nutrition and Food Science. 2021;26(3):241-261
  15. 15. Astley SB. Encyclopedia of food sciences and nutrition. In: Antioxidants | Role of Antioxidant Nutrients in Defense Systems. 2003. pp. 282-289
  16. 16. Mangels AR, Holden JM, Beecher GR, Forman MR, Lanza E. Carotenoid content of fruits and vegetables: An evaluation of analytic data. Journal of the American Dietetic Association. 1993;93(3):284-296
  17. 17. Holden JM, Eldridge AL, Beecher GR, Buzzard IM, Bhagwat S, Davis CS, et al. Carotenoid content of US foods: An update of the database. Journal of Food Composition and Analysis. 1999;12(3):169-196
  18. 18. Tanumihardjo SA. Carotenoids: Health effects. In: Caballero B, editor. Encyclopedia of Human Nutrition. 3rd ed. Oxford, UK: Academic Press; 2013. pp. 292-297
  19. 19. Harrison EH. Mechanisms involved in the intestinal absorption of dietary vitamin A and provitamin A carotenoids. Biochemistry and Biophysics Acta. 2012;1821:70-77
  20. 20. Wawrzyniak A, Hamułka J, Friberg E, Wolk A. Dietary, anthropometric, and lifestyle correlates of serum carotenoids in postmenopausal women. European Journal of Nutrition. 2013;52:1919-1926
  21. 21. Stahl W, Sies H. Antioxidant activity of carotenoids. Molecular Aspects of Medicine. 2003;24:345-351
  22. 22. Bendich A. Non-provitamin A activity of carotenoids: Immunoenhancement. Trends in Food Science & Technology. 1991;2:127-130
  23. 23. Liebler DC, McClure TD. Antioxidant reactions of β-carotene: Identification of carotenoid− Radical adducts. Chemical Research in Toxicology. 1996;9(1):8-11
  24. 24. Fiedor J, Burda K. Potential role of carotenoids as antioxidants in human health and disease. Nutrients. 2014;6:466-488
  25. 25. Böhm V, Lietz G, Olmedilla-Alonso B, Phelan D, Reboul E, Bánati D, et al. From carotenoid intake to carotenoid blood and tissue concentrations–Implications for dietary intake recommendations. Nutrition Reviews. 2021;79(5):544-573
  26. 26. Burri BJ. Beta-cryptoxanthin as a source of vitamin A. Journal of the Science of Food and Agriculture. 2015;95(9):1786-1794
  27. 27. Burri BJ, La Frano MR, Zhu C. Absorption, metabolism, and functions of β-cryptoxanthin. Nutrition Reviews. 2016;74(2):69-82
  28. 28. Coronel J, Pinos I, Amengual J. β-carotene in obesity research: Technical considerations and current status of the field. Nutrients. 2019;11(4):842
  29. 29. Jiao Y, Reuss L, Wang Y. β-Cryptoxanthin: Chemistry, occurrence, and potential health benefits. Current Pharmacology Reports. 2019;5:20-34
  30. 30. Krinsky NI, Johnson EJ. Carotenoid actions and their relation to health and disease. Molecular Aspects of Medicine. 2005;26(6):459-516
  31. 31. Xu X, Jiang L, Zhang Z, Shi Y, Huang H. Genome sequence of a gamma-and uv-ray-resistant strain, Deinococcus wulumuqiensis R12. Genome Announcements. 2013;1:e00206-e00213
  32. 32. Woodside JV, McGrath AJ, Lyner N, McKinley MC. Carotenoids and health in older people. Maturitas. 2015;80:63-68
  33. 33. Eisenhauer B, Natoli S, Liew G, Flood VM. Lutein and zeaxanthin–food sources, bioavailability and dietary variety in age-related macular degeneration protection. Nutrients. 2017;9:120
  34. 34. Cho KS, Shin M, Kim S, Lee SB. Recent advances in studies on the therapeutic potential of dietary carotenoids in neurodegenerative diseases. Oxidative Medicine and Cellular Longevity. 16 Apr 2018;2018:4120458
  35. 35. Di Mascio P, Kaiser S, Sies H. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Archives of Biochemistry and Biophysics. 1989;274(2):532-538
  36. 36. Luo C, Wu XG. Lycopene enhances antioxidant enzyme activities and immunity function in N-methyl-N’-nitro-N-nitrosoguanidine-enduced gastric cancer rats. International Journal of Molecular Sciences. 2011;12:3340-3351
  37. 37. Agarwal S, Rao AV. Tomato lycopene and its role in human health and chronic diseases. CMAJ. 2000;163:739-744
  38. 38. Liu CC, Huang CC, Lin WT, Hsieh CC, Huang SY, Lin SJ, et al. Lycopene supplementation attenuated xanthine oxidase and myeloperoxidase activities in skeletal muscle tissues of rats after exhaustive exercise. British Journal of Nutrition. 2005;94:595-601
  39. 39. Neyestani TR, Shariatzadeh N, Gharavi A, Kalayi A, Khalaji N. Physiological dose of lycopene suppressed oxidative stress and enhanced serum levels of immunoglobulin m in patients with type 2 diabetes mellitus: A possible role in the prevention of long-term complications. Journal of Endocrinological Investigation. 2007;30:833-838
  40. 40. Story EN, Kopec RE, Schwartz SJ, Harris GK. An update on the health effects of tomato lycopene. Annual Review of Food Science and Technology. 2010;1:189-210
  41. 41. Aydin S, Palabiyik SS, Erkekoglu P, Sahin G, Başaran N, Giray BK. The carotenoid lycopene protects rats against DNA damage induced by ochratoxin A. Toxicon. 2013;73:96-103
  42. 42. Wang J, Suo Y, Zhang J, Zou Q, Tan X, Yuan T, et al. Lycopene supplementation attenuates western diet-induced body weight gain through increasing the expressions of thermogenic/mitochondrial functional genes and improving insulin resistance in the adipose tissue of obese mice. Journal of Nutritional Biochemistry. 2019a;69:63-72
  43. 43. Wang J, Wang Z, Li B, Qiang Y, Yuan T, Tan X, et al. Lycopene attenuates western-diet-induced cognitive deficits via improving glycolipid metabolism dysfunction and inflammatory responses in gut-liver-brain axis. International Journal of Obesity. 2019b;43:1735-1746
  44. 44. Saini RK, Prasad P, Lokesh V, Shang X, Shin J, Keum YS, et al. Carotenoids: Dietary sources, extraction, encapsulation, bioavailability, and health benefit—A review of recent advancements. Antioxidants (Basel, Switzerland). 2022;11(4):795
  45. 45. Harp BP, Barrows JN. US regulation of color additives in foods. In: Scotter MJ, editor. Colour Additives for Foods and Beverages. Oxford: Woodhead Publishing; 2015. pp. 75-88
  46. 46. Britton G, Khachik F. Carotenoids in food. In: Britton G, Pfander H, Liaaen Jensen S, editors. Carotenoids: Volume 5: Nutrition and Health, Carotenoids. Basel: Birkhäuser; 2009. pp. 45-66
  47. 47. Johnson EJ. The role of carotenoids in human health. Nutrition in Clinical Care: An Official Publication of Tufts University. 2002;5(2):56-65
  48. 48. Heinrich U, Gartner C, Wiebusch M, Eichler O, Sies H, Tronnier H, et al. Supplementation with beta-carotene or a similar amount of mixed carotenoids protects humans from UV-induced erythema. The Journal of Nutrition. 2003;133:98-101
  49. 49. Katayama S, Ogawa H, Nakamura S. Apricot carotenoids possess potent anti-amyloidogenic activity in vitro. Journal of Agricultural and Food Chemistry. 2011;59(23):12691-12696
  50. 50. Zhang Y, Lui Z, Sun J, Xue C, Mao X. Biotechnological production of zeaxanthin by microorganisms. Trends in Food Science and Technology. 2018;71:225-234
  51. 51. Bhatt T, Patel K. Carotenoids: Potent to prevent diseases review. Natural Products and Bioprospecting. Jun 2020;10(3):109-117
  52. 52. Almeida TP, Ramos AA, Ferreira J, Azqueta A, Rocha E. Bioactive compounds from seaweed with anti-leukemic activity: A mini-review on carotenoids and phlorotannins. Mini-Reviews in Medicinal Chemistry. 2020;20:39-53
  53. 53. Eggersdorfer M, Wyss A. Carotenoids in human nutrition and health. Archives of Biochemistry and Biophysics. 2018;652:18-26
  54. 54. Milani A, Basirnejad M, Shahbazi S, Bolhassani A. Carotenoids: Biochemistry, pharmacology and treatment. British Journal of Pharmacology. 2017;174(11):1290-1324
  55. 55. Black HS, Boehm F, Edge R, Truscott TG. The benefits and risks of certain dietary carotenoids that exhibit both anti- and pro-oxidative mechanisms-A comprehensive review. Antioxidants (Basel, Switzerland). 2020;9(3):264
  56. 56. Tavakoli S, Asmis R. Reactive oxygen species and thiol redox signaling in the macrophage biology of atherosclerosis. Antioxidants & Redox Signaling. 2012;17(12):1785-1795
  57. 57. Kirti K, Amita S, Priti S, Mukesh Kumar A, Jyoti S. Colorful world of microbes: Carotenoids and their applications. Advances in Biology. 2014;2014:1-3
  58. 58. Sachdeva AK, Chopra K. Lycopene abrogates Aβ (1-42)-mediated neuroinflammatory cascade in an experimental model of Alzheimer’s disease. The Journal of Nutritional Biochemistry. 2015;26(7):736-744
  59. 59. Mullan K, Williams MA, Cardwell CR, McGuinness B, Passmore P, Silvestri G, et al. Serum concentrations of vitamin E and carotenoids are altered in Alzheimer’s disease: A case-control study. Alzheimer’s & Dementia: Translational Research & Clinical Interventions. 2017;3(3):432-439
  60. 60. Feart C, Letenneur L, Helmer C, Samieri C, Schalch W, Etheve S, et al. Plasma carotenoids are inversely associated with dementia risk in an elderly French cohort. Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences. 2016;71(5):683-688
  61. 61. Arzi L, Hoshyar R, Jafarzadeh N, Riazi G, Sadeghizadeh M. Anti-metastatic properties of a potent herbal combination in cell and mice models of triple negative breast cancer. Life Sciences. 2020;243:117-245
  62. 62. Cheng HM, Koutsidis G, Lodge JK, Ashor AW, Siervo M, Lara J. Lycopene and tomato and risk of cardiovascular diseases: A systematic review and meta-analysis of epidemiological evidence. Critical Reviews in Food Science and Nutrition. 2019;59(1):141-158
  63. 63. Di Pietro N, Di Tomo P, Pandolfi A. Carotenoids in cardiovascular disease prevention. JSM Atherosclerosis. 2016;1(1):1002
  64. 64. Rucker Robert B, James M, Fascetti Andrea J. Clinical Biochemistry of Domestic Animals. Vitamins; 2008. pp. 695-730
  65. 65. Roohbakhsh A, Karimi G, Iranshahi M. Carotenoids in the treatment of diabetes mellitus and its complications: A mechanistic review. Biomedicine & Pharmacotherapy. 2017;91:31-42
  66. 66. Berendschot TT, Plat J. Plant stanol and sterol esters and macular pigment optical density. In: Handbook of Nutrition, Diet and the Eye. Academic Press; 2014. pp. 441-449
  67. 67. Shidfar F, Arjomand GN. Glucose intake and utilization in pre-diabetes and diabetes: Tomato and diabetes. In: Glucose Intake and Utilization in Pre-Diabetes and Diabetes. Academic Press; 2015. pp. 301-313
  68. 68. Schmitz HH, Poor CL, Wellman RB, Erdman JW Jr. Concentrations of selected carotenoids and vitamin a in human liver, kidney and lung tissue. The Journal of Nutrition. 1991;121(10):1613-1621
  69. 69. Sathasivam R, Ki JS. A review of the biological activities of microalgal carotenoids and their potential use in healthcare and cosmetic industries. Marine Drugs. 2018;16(1):26
  70. 70. Zhao WE, Shi G, Gu H, Ngoc NB. Role of PPARγ in the nutritional and pharmacological actions of carotenoids. Research and Reports in Biochemistry. 2016:13-24

Written By

Anju Singh and Kamya Omer

Submitted: 26 June 2023 Reviewed: 17 July 2023 Published: 20 March 2024